Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Canada awaits formal HTA (health technology assessment)

This article was originally published in Clinica

Executive Summary

The Canadian medical device industry sees the introduction of a formal health technology assessment (HTA) system as increasingly inevitable.

You may also be interested in...



Emerging Markets Help Fresenius Kabi Offset US Pressures

Fresenius Kabi has reported sales ahead by 6% in 2019, as growth in emerging markets helped to offset a subdued increase in North America. Meanwhile, the firm has pushed back financial expectations for its biosimilars by a year.

Fresenius Kabi And Vifor Ally In China

Fresenius Kabi and Vifor Pharma have agreed to create a joint venture in China for intravenous iron products.

Digital And AI Capabilities Essential For Diagnostic Success Says German Industry

The value of rare disease research must not be overlooked as the drive to diagnose and contain coronavirus mounts.

Topics

UsernamePublicRestriction

Register

MT070401

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel